新华医疗
(600587)
| 流通市值：96.63亿 | | | 总市值：97.37亿 |
| 流通股本：6.02亿 | | | 总股本：6.07亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,474,624,687.68 | 2,894,880,797.16 | 2,774,997,885.38 | 3,188,296,441.67 |
| 应收票据及应收账款 | 2,223,835,058.62 | 2,123,586,427.2 | 1,960,009,917.6 | 1,858,881,428.16 |
| 其中：应收票据 | 192,117,120 | 174,444,415.24 | 148,082,085.47 | 164,048,949.42 |
| 应收账款 | 2,031,717,938.62 | 1,949,142,011.96 | 1,811,927,832.13 | 1,694,832,478.74 |
| 应收款项融资 | 72,527,581.11 | 90,303,942.62 | 77,368,815.48 | 98,671,231.73 |
| 预付款项 | 282,249,338.52 | 195,102,449.24 | 305,279,563.4 | 166,717,551.88 |
| 其他应收款合计 | 605,410,991.25 | 283,517,924.42 | 268,925,554.81 | 238,494,581.7 |
| 其中:应收利息 | 905,960.12 | 906,005.84 | 906,125.88 | 923,360.79 |
| 应收股利 | 124,110,810.13 | 124,110,810.13 | 98,969,119.68 | 108,044,119.68 |
| 存货 | 3,441,900,783.28 | 3,565,779,788.37 | 3,644,339,136.32 | 3,555,786,774.42 |
| 合同资产 | 132,809,463.69 | 130,749,367.82 | 122,374,864 | 113,785,480.39 |
| 一年内到期的非流动资产 | 15,557,788.76 | 23,546,101.68 | 38,195,200.13 | 38,195,200.13 |
| 其他流动资产 | 73,587,056.49 | 68,739,322.66 | 85,154,678.75 | 95,406,699.87 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 9,367,034,360.25 | 9,423,737,732.02 | 9,317,526,660.99 | 9,454,331,945.33 |
| 非流动资产: | | | | |
| 长期应收款 | 9,530,627.12 | 9,779,486.54 | 14,393,472.25 | 14,782,589.01 |
| 长期股权投资 | 1,488,841,800.85 | 1,637,293,153.9 | 1,646,870,392.59 | 1,633,724,381.31 |
| 其他权益工具投资 | 42,480,444.89 | 42,480,444.89 | 42,480,444.89 | 42,480,444.89 |
| 其他非流动金融资产 | 96,219,064.8 | 96,219,064.8 | 100,432,756.6 | 111,028,358.61 |
| 投资性房地产 | 306,852,470.88 | 310,114,956.27 | 311,221,861.36 | 313,569,578.7 |
| 固定资产 | 2,214,169,443.05 | 2,226,955,528.05 | 2,185,752,196.41 | 2,217,826,263.46 |
| 在建工程 | 817,141,884.45 | 757,070,380.96 | 768,414,492.79 | 739,968,168.95 |
| 使用权资产 | 44,840,255.78 | 47,866,901.02 | 51,165,385.12 | 55,179,599.32 |
| 无形资产 | 475,989,890.21 | 472,143,000.34 | 472,548,771.53 | 478,057,517.37 |
| 商誉 | 257,264,985.95 | 257,264,985.95 | 257,264,985.95 | 257,264,985.95 |
| 长期待摊费用 | 120,043,826.03 | 121,054,157.52 | 121,420,044.69 | 123,327,959.37 |
| 递延所得税资产 | 114,847,212.26 | 116,092,000.95 | 117,492,696.52 | 115,959,767.75 |
| 其他非流动资产 | 33,963,948.5 | 34,913,239.01 | 39,973,588.01 | 32,828,215.21 |
| 非流动资产平衡项目 | -0.01 | 0 | 0 | 0 |
| 非流动资产合计 | 6,022,185,854.76 | 6,129,247,300.2 | 6,129,431,088.71 | 6,135,997,829.9 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 15,389,220,215.01 | 15,552,985,032.22 | 15,446,957,749.7 | 15,590,329,775.23 |
| 流动负债: | | | | |
| 短期借款 | 871,454,954.46 | 892,623,151.26 | 849,734,411.69 | 851,947,102.23 |
| 应付票据及应付账款 | 2,523,257,134.75 | 2,589,868,252.62 | 2,573,142,243.09 | 2,443,285,698.54 |
| 其中：应付票据 | 450,252,544.59 | 577,717,094.82 | 576,407,707.27 | 291,431,225.42 |
| 应付账款 | 2,073,004,590.16 | 2,012,151,157.8 | 1,996,734,535.82 | 2,151,854,473.12 |
| 合同负债 | 2,140,506,941.31 | 2,170,238,878.25 | 2,249,239,920.19 | 2,336,278,758.11 |
| 应付职工薪酬 | 199,167,732.23 | 197,385,408.68 | 173,072,035.32 | 339,849,042.21 |
| 应交税费 | 100,233,322.89 | 105,934,297.07 | 64,115,290.02 | 93,464,360.95 |
| 其他应付款合计 | 824,708,943.93 | 867,393,525.4 | 820,354,635.4 | 1,001,050,068.32 |
| 应付股利 | 4,817,741.8 | 92,510,355.25 | 25,116,364.51 | 62,539,361.33 |
| 一年内到期的非流动负债 | 52,305,617.05 | 53,715,363.04 | 40,759,896.74 | 51,289,191.25 |
| 其他流动负债 | 424,125,058.62 | 405,407,788.01 | 417,489,459.9 | 400,027,196.7 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 7,135,759,705.24 | 7,282,566,664.33 | 7,187,907,892.35 | 7,517,191,418.31 |
| 非流动负债: | | | | |
| 长期借款 | 139,497,916.75 | 134,032,250.08 | 178,225,906.3 | 137,797,145.91 |
| 租赁负债 | 33,831,827.85 | 31,862,504.97 | 34,333,679.37 | 37,326,438.31 |
| 长期应付款 | 1,885,929.88 | 1,999,415.85 | 1,929,043.41 | 624,225.72 |
| 预计负债 | - | 19,850,000 | 19,850,000 | 19,850,000 |
| 递延收益 | 77,433,318.1 | 64,568,736.63 | 64,785,906.94 | 61,668,321.87 |
| 递延所得税负债 | 98,254,485.09 | 94,838,268.01 | 94,919,733.03 | 96,036,554.53 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 350,903,477.67 | 347,151,175.54 | 394,044,269.05 | 353,302,686.34 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 7,486,663,182.91 | 7,629,717,839.87 | 7,581,952,161.4 | 7,870,494,104.65 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 606,686,586 | 606,686,586 | 466,681,989 | 466,681,989 |
| 其他权益工具 | -73,577,993.14 | -73,577,993.14 | -73,577,993.14 | - |
| 资本公积 | 2,711,699,831.09 | 2,868,438,442.47 | 3,004,950,092.38 | 3,000,148,403 |
| 减:库存股 | 60,283,788 | 60,283,788 | 60,283,788 | 60,283,788 |
| 其他综合收益 | 16,457,187.18 | 16,457,187.18 | 16,394,293.05 | 16,394,293.05 |
| 专项储备 | 34,294,402.27 | 32,401,525.74 | 31,713,434.98 | 28,686,532.25 |
| 盈余公积 | 350,760,570.59 | 350,760,570.59 | 350,760,570.59 | 350,760,570.59 |
| 未分配利润 | 3,899,902,984.06 | 3,767,158,374.68 | 3,727,274,020.67 | 3,516,237,200.55 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,485,939,780.05 | 7,508,040,905.52 | 7,463,912,619.53 | 7,318,625,200.44 |
| 少数股东权益 | 416,617,252.05 | 415,226,286.83 | 401,092,968.77 | 401,210,470.14 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,902,557,032.1 | 7,923,267,192.35 | 7,865,005,588.3 | 7,719,835,670.58 |
| 负债和股东权益合计 | 15,389,220,215.01 | 15,552,985,032.22 | 15,446,957,749.7 | 15,590,329,775.23 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-30 | 2024-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |